scispace - formally typeset
Search or ask a question
Topic

Bacillus anthracis

About: Bacillus anthracis is a research topic. Over the lifetime, 3994 publications have been published within this topic receiving 128122 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: It is demonstrated that the presence and level of a bacterial antigen, the protective antigen (PA), a component of B. anthracis toxins, in host sera can serve as a reliable marker of infection.
Abstract: The most aggressive form of anthrax results from inhalation of airborne spores of Bacillus anthracis and usually progresses unnoticed in the early stages because of unspecific symptoms. The only reliable marker of anthrax is development of bacteremia, which increases with disease progress. Rapid diagnosis of anthrax is imperative for efficient treatment and cure. Herein we demonstrate that the presence and level of a bacterial antigen, the protective antigen (PA), a component of B. anthracis toxins, in host sera can serve as a reliable marker of infection. This was tested in two animal models of inhalation anthrax, rabbits and guinea pigs infected by intranasal instillation of Vollum spores. In both models, we demonstrated qualitative and quantitative correlations between levels of bacteremia and PA concentrations in the sera of sick animals. The average time to death in infected animals was about 16 h after the appearance of bacteremia, leaving a small therapeutic window. As the time required for immunodetection of PA can be very short, the use of this marker will be beneficial for faster diagnosis and treatment of inhalation anthrax.

77 citations

Journal ArticleDOI
TL;DR: It is demonstrated that spores lose heat resistance and become hydrated in the presence of nisin, thereby ruling out a possible mechanism of inhibition in which nisin acts to block germination initiation, and that nisin rapidly and irreversibly inhibits growth.
Abstract: The lantibiotic nisin has previously been reported to inhibit the outgrowth of spores from several Bacillus species. However, the mode of action of nisin responsible for outgrowth inhibition is poorly understood. By using B. anthracis Sterne 7702 as a model, nisin acted against spores with a 50% inhibitory concentration (IC50) and an IC90 of 0.57 μM and 0.90 μM, respectively. Viable B. anthracis organisms were not recoverable from cultures containing concentrations of nisin greater than the IC90. These studies demonstrated that spores lose heat resistance and become hydrated in the presence of nisin, thereby ruling out a possible mechanism of inhibition in which nisin acts to block germination initiation. Rather, germination initiation is requisite for the action of nisin. This study also revealed that nisin rapidly and irreversibly inhibits growth by preventing the establishment of oxidative metabolism and the membrane potential in germinating spores. On the other hand, nisin had no detectable effects on the typical changes associated with the dissolution of the outer spore structures (e.g., the spore coats, cortex, and exosporium). Thus, the action of nisin results in the uncoupling of two critical sequences of events necessary for the outgrowth of spores: the establishment of metabolism and the shedding of the external spore structures.

77 citations

Journal ArticleDOI
TL;DR: It is proposed that the Asp-683 carboxylate group of protective antigen completes the coordination of the MIDAS metal of ATR, mimicking integrin-ligand interactions.

77 citations

Journal ArticleDOI
TL;DR: In this paper, it was shown that when spores of specific toxin-null mutants are introduced into the lung, dissemination and lethality are comparable to those of the parent strain in a murine model of inhalation anthrax.
Abstract: Bacillus anthracis, the etiologic agent of anthrax, produces at least three primary virulence factors: lethal toxin, edema toxin, and a capsule. The capsule is absolutely required for dissemination and lethality in a murine model of inhalation anthrax, yet the roles for the toxins during infection are ill-defined. We show in a murine model that when spores of specific toxin-null mutants are introduced into the lung, dissemination and lethality are comparable to those of the parent strain. Mutants lacking one or more of the structural genes for the toxin proteins, i.e., protective antigen, lethal factor, and edema factor, disseminated from the lung to the spleen at rates similar to that of the virulent parental strain. The 50% lethal dose (LD50) and mean time to death (MTD) of the mutants did not differ significantly from those of the parent. The LD50s or MTDs were also unaffected relative to those of the parent strain when mice were inoculated intravenously with vegetative cells. Nonetheless, histopathological examination of tissues revealed subtle but distinct differences in infections by the parent compared to some toxin mutants, suggesting that the host response is affected by toxin proteins synthesized during infection.

77 citations

Journal ArticleDOI
TL;DR: The pX01 influence on capsule synthesis is mediated by AtxA, the pXO1-encoded trans-activator of the toxin gene expression, which indicates that fully virulent Bacillus anthracis bacilli are encapsulated and toxinogenic.
Abstract: Fully virulent Bacillus anthracis bacilli are encapsulated and toxinogenic. These bacteria carry two plasmids, pXO1 and pXO2, encoding toxins and capsule synthetic-enzymes (capB, C, A, dep), respectively. The pXO1 plasmid strongly enhances capsule formation. This influence was studied by analysing the expression of a capB–lacZ fusion in various backgrounds. The β-galactosidase activities were similar in a ΔatxA strain and a pXO1 cured strain. Moreover, the capB–lacZ expression level could be restored, in a pXO1 cured strain, by addition of atxA in trans. Thus, we conclude that the pXO1 influence on capsule synthesis is mediated by AtxA, the pXO1-encoded trans-activator of the toxin gene expression.

77 citations


Network Information
Related Topics (5)
Escherichia coli
59K papers, 2M citations
88% related
Virulence
35.9K papers, 1.3M citations
87% related
Plasmid
44.3K papers, 1.9M citations
84% related
Drug resistance
28.4K papers, 1.1M citations
82% related
Antibody
113.9K papers, 4.1M citations
80% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
20241
202381
2022169
202181
2020116
2019106